1.
Transgenic Res
; 26(5): 709-713, 2017 10.
Artículo
en Inglés
| MEDLINE
| ID: mdl-28730514
RESUMEN
In this consensus paper resulting from a meeting that involved representatives from more than 20 European partners, we recommend the foundation of an expert group (European Steering Committee) to assess the potential benefits and draw-backs of genome editing (off-targets, mosaicisms, etc.), and to design risk matrices and scenarios for a responsible use of this promising technology. In addition, this European steering committee will contribute in promoting an open debate on societal aspects prior to a translation into national and international legislation.
Asunto(s)
Biotecnología/tendencias , Sistemas CRISPR-Cas/genética , Edición Génica/métodos , Biotecnología/métodos , Europa (Continente) , Humanos
2.